Biochemistry and biological effects of the pyrazofurins (pyrazomycins): initial clinical trial.
D000577:Amides; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003597:Cytosine Nucleotides / Q000097:blood; D004353:Drug Evaluation, Preclinical; D005260:Female; D005622:Friend murine leukemia virus; D007942:Leukemia, Experimental / Q000188:drug therapy; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D011720:Pyrazoles; D012263:Ribonucleosides / Q000627:therapeutic use*; D012266:Ribose; D013302:Streptomyces; D013329:Structure-Activity Relationship
D000577:Amides; D000900:Anti-Bacterial Agents; D003597:Cytosine Nucleotides; D011720:Pyrazoles; D012263:Ribonucleosides; C002997:pyrazofurin; D012266:Ribose